BEDOGNETTI, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 3.502
Totale 3.502
Nazione #
IT - Italia 3.502
Totale 3.502
Città #
Genova 2.759
Genoa 366
Rapallo 290
Vado Ligure 82
Bordighera 5
Totale 3.502
Nome #
Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors. 155
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 151
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 131
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. 131
Gene-expression profiling in vaccine therapy and immunotherapy for cancer. 127
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer 114
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis. 112
Inherent transcriptional signatures of NK cells are associated with response to IFNΑ+rivabirin therapy in patients with Hepatitis C Virus 111
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 111
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial 111
Combination of sorafenib and weekly gemcitabine in patients (pts) with metastatic renal cell Cancer (MRCC): A phase II study, preliminary results 108
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: Meta-analysis of individual patient data from ten randomised trials 108
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 105
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 89
Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer 79
An Open, Randomised, Multicentre, Phase 3 Trial Comparing the Efficacy of Two Tamoxifen Schedules in Preventing Gynaecomastia Induced by Bicalutamide Monotherapy in Prostate Cancer Patients 77
Toward a comprehensive view of cancer immune responsiveness: A synopsis from the SITC workshop 77
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications 75
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis 71
Monoallelic expression in melanoma 71
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk 66
Conservation of immune gene signatures in solid tumors and prognostic implications 65
A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification 62
Checkpoint Inhibitors and Their Application in Breast Cancer 61
Disentangling the relationship between tumor genetic programs and immune responsiveness 61
Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications 61
Harnessing the immune system for the treatment of melanoma: current status and future prospects 60
Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells 60
Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype 60
Photodynamic therapy based on graphene and MXene in cancer theranostics 59
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod 58
Immunogenic subtypes of breast cancer delineated by gene classifiers of immune responsiveness 57
The immune-related role of BRAF in melanoma 57
Sterol synthesis pathway inhibition as a target for cancer treatment 56
Molecular and Genomic Impact of Large and Small Lateral Dimension Graphene Oxide Sheets on Human Immune Cells from Healthy Donors 53
Long-Chain Acyl-CoA Synthetase 1 Role in Sepsis and Immunity: Perspectives From a Parallel Review of Public Transcriptome Datasets and of the Literature 53
Pharmacogenetics driving personalized medicine: Analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations 52
The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy 51
Prognostic and predictive immune gene signatures in breast cancer 51
The ovarian cancer Chemokine landscape is conducive to homing of vaccine-primed and CD3/CD28-Costimulated T cells prepared for adoptive therapy 51
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) 51
The Immune Landscape of Cancer 50
Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients 49
Correction to: Toward a comprehensive view of cancer immune responsiveness: A synopsis from the SITC workshop (Journal for ImmunoTherapy of Cancer (2020) 7 (131) DOI: 10.1186/s40425-019-0602-4) 49
A modular framework for the development of targeted Covid-19 blood transcript profiling panels 37
Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: A study protocol 33
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response 30
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer 30
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 27
An integrated tumor, immune and microbiome atlas of colon cancer 17
Totale 3.641
Categoria #
all - tutte 13.559
article - articoli 13.559
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.145 0 0 16 52 52 61 216 167 220 205 103 53
2020/2021656 20 75 13 113 180 35 5 66 13 94 15 27
2021/2022558 31 21 34 68 13 36 44 123 57 48 21 62
2022/2023384 47 40 13 23 50 53 3 26 44 5 71 9
2023/2024275 7 43 9 47 19 27 6 23 22 7 22 43
2024/202590 17 55 18 0 0 0 0 0 0 0 0 0
Totale 3.641